Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.20ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.5.2.20ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.5.2.20SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
BA.5.2.20SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
BA.5.2.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-2052.38South Korea
BQ.1.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
BQ.1.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-775.945South Korea
BQ.1.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-1215.87South Korea
BQ.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DV.3ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-2052.38South Korea
DV.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
DV.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
DV.3SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
DV.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DV.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.1.8ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-2052.38South Korea
BA.4.1.8ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
BA.4.1.8SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.4.1.8SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.4.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.3ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-2052.38South Korea
BN.1.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
BN.1.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BN.1.3SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BN.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.22ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-2052.38South Korea
BA.5.1.22ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
BA.5.1.22SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.1.22SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.5.1.22EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used